Tandem Diabetes Care, Inc. Advertising Expense
Tandem Diabetes Care, Inc. (TNDM) reported Advertising Expense of $900.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2020-02-24
- Tandem Diabetes Care, Inc. advertising expense for fiscal 2019 was $900.00K, a 0.00% change from fiscal 2018.
- Tandem Diabetes Care, Inc. advertising expense for fiscal 2018 was $900.00K, a 18.18% decline from fiscal 2017.
- Tandem Diabetes Care, Inc. advertising expense for fiscal 2017 was $1.10M, a 22.22% increase from fiscal 2016.
- Tandem Diabetes Care, Inc. advertising expense for fiscal 2016 was $900.00K, a 10.00% decline from fiscal 2015.
| Period end | Advertising Expense 12 month |
|---|---|
| 2019-12-31 | $900.00K 10-K · filed 2020-02-24 |
| 2018-12-31 | $900.00K 10-K · filed 2020-02-24 |
| 2017-12-31 | $1.10M 10-K · filed 2020-02-24 |
| 2016-12-31 | $900.00K 10-K · filed 2019-02-26 |
| 2015-12-31 | $1.00M 10-K · filed 2018-03-01 |
| 2014-12-31 | $1.50M 10-K · filed 2017-03-08 |
| 2013-12-31 | $700.00K 10-K · filed 2016-02-24 |
| 2012-12-31 | $68.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |